HPV E6 protein regulation of the hTERT promoter
HPV E6 protein regulation of the hTERT promoter
批准号:
7274152
负责人:
Richard Schlegel
金额:
$29.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-16 至 2009-06-30
关键词:
Applications GrantsBindingBinding SitesBiologicalBoxingCancer EtiologyCatalytic DomainCell Cycle ProteinsCell Differentiation processCell ProliferationCellsChromosomesDataDifferentiation and GrowthEventGene ExpressionGenesGenetic TranscriptionGoalsGrantHPV-High RiskHistone AcetylationHistone DeacetylaseHuman PapillomavirusIn VitroLaboratoriesLengthMaintenanceMalignant NeoplasmsMalignant neoplasm of cervix uteriMediatingMediator of activation proteinMolecularMultienzyme ComplexesNF-kappa BOncogene ProteinsOncogenicPapillomavirusPhenotypePlayProcessProtein OverexpressionProtein p53ProteinsPublishingRateRegulationRiskRoleTP53 geneTechniquesTelomeraseTransactivationTumor Suppressor ProteinsWomanZinc Fingersbasecell growthcell immortalizationchromatin immunoprecipitationgenetic regulatory proteinhuman RCN2 proteinhuman TERT proteinhuman UBE3A proteinin vivokeratinocytemalignant statemutantpromoterprotein functiontelomeretranscription factor
中文摘要
描述(申请人提供):在世界范围内,宫颈癌是女性癌症的第二大原因,而人乳头瘤病毒在这种恶性肿瘤的发生中起着关键的作用。乳头瘤病毒编码两种癌蛋白E6和E7,它们是启动和维持恶性状态以及诱导细胞永生化所必需的。其中一些生物活性似乎与E6和E7分别降解细胞P53和Rb抑癌蛋白的能力有关。然而,与其降解P53的能力无关,E6可以诱导细胞端粒酶活性,从而可能维持染色体端粒长度和持续的细胞增殖。细胞端粒酶活性的限速事件是hTERT蛋白的水平,hTERT是酶复合体的催化亚单位。我们和其他人已经证明,E6蛋白反式激活hTERT启动子,导致hTERT蛋白和细胞端粒酶活性增加。我们最新的研究表明,E6蛋白与Myc蛋白结合,两者结合并协同激活hTERT启动子。有趣的是,只有高危的E6蛋白与hTERT启动子结合,进一步支持了端粒酶的诱导和细胞永生化之间的相关性。目前的方案研究了E6与Myc结合、结合hTERT启动子和促进基因转录的机制。此外,我们将研究E6是否增加了Myc调节的其他基因,以及Myc是否可以模拟E6特有的细胞表型的子集。拨款的总体目标是了解E6在调节基因转录、细胞生长和细胞分化方面的作用。
英文摘要
DESCRIPTION (provided by applicant): Worldwide, cervical cancer is the second leading cause of cancer in women and the "high risk" human papillomaviruses play a critical role in the genesis of this malignancy. The papillomaviruses encode two oncoproteins, E6 and E7, that are required for the initiation and maintenance of the malignant state as well as the induction of cell immortalization. Several of these biological activities appear related to the ability of E6 and E7 to degrade the cellular p53 and Rb tumor suppressor proteins, respectively. However, independent of its ability to degrade p53, E6 can induce cellular telomerase activity and, presumably, thereby maintain chromosome telomere length and continued cell proliferation. The rate-limiting event in cellular telomerase activity is the level of hTERT protein, the catalytic subunit of the enzyme complex. We and others have shown that the E6 protein transactivates the hTERT promoter, leading to an increase in hTERT protein and cellular telomerase activity. Our most recent studies indicate that the E6 protein associates with Myc protein and that they both bind and cooperatively activate the hTERT promoter. Interestingly, only the "high risk" E6 proteins bind the hTERT promoter, further supporting the correlation between induction of telomerase and cell immortalization. The current proposal investigates the mechanism by which E6 associates with Myc, binds the hTERT promoter, and facilitates gene transcription. In addition, we will examine whether E6 augments other Myc-regulated genes and whether Myc can mimic a subset of E6-specific cellular phenotypes. The overall goal of the grant is to gain an understanding of the role of E6 in regulating gene transcription, cell growth and cell differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8547303
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8899468
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8727495
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8516613
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8725249
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8137493
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8322566
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
A topical treatment for genital papillomavirus infections
-
批准号:7286845
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2006
-
负责人:Richard Schlegel
-
依托单位:
A topical treatment for genital papillomavirus infections
-
批准号:7174571
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2006
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:6757107
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7114631
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
Treatment of Cervical Cancer with Artemisinin
-
批准号:6948533
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7115758
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:6949542
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
Treatment of Cervical Cancer with Artemisinin
-
批准号:6823604
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7488862
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
DNA CONFORMATION DEPENDENT REGULATOR OF GENE EXPRESSION
-
批准号:2896082
-
项目类别:
-
资助金额:$23.6万
-
财政年份:1997
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE
-
批准号:2098706
-
项目类别:
-
资助金额:$25.16万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE
-
批准号:2098705
-
项目类别:
-
资助金额:$23.88万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS: MODEL FOR A VACCINE
-
批准号:3202287
-
项目类别:
-
资助金额:$23.6万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: